“Benlysta emerges as a direct approach in lupus treatment. Developed by Human Genome Sciences and GlaxoSmith Kline, the drug is based on research done at the LMB and the Scripps Research Institute.” More…
Home > LMB In The News > New drug Benlysta in Lupus treatment